CRISPR Therapeutics announced that Brad Bolzon, Ph.D., Chairman and Managing Director of Versant Ventures, is stepping down from the Board of Directors after nearly a decade of service.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58.26 USD | +1.94% | +6.24% | -6.93% |
May. 23 | CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer | MT |
May. 23 | CRISPR Therapeutics Announces Executive Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.93% | 4.85B | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- CRSP Stock
- News CRISPR Therapeutics AG
- CRISPR Therapeutics AG Announces Resignation of Brad Bolzon to Board of Directors